Cannabis and Tobacco Co-Use Is Associated With Impaired Neurocognitive Performance in Individuals at Clinical High Risk for Psychosis.

Saved in:
Bibliographic Details
Title: Cannabis and Tobacco Co-Use Is Associated With Impaired Neurocognitive Performance in Individuals at Clinical High Risk for Psychosis.
Authors: Bello D; Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, Tennessee., Connolly JG; Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, Tennessee., Addington J; Department of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada., Bearden CE; Semel Institute for Neuroscience and Human Behavior, Departments of Psychiatry and Behavioral Sciences and Psychology, University of California Los Angeles, Los Angeles, California., Cadenhead K; Department of Psychiatry, University of California San Diego, La Jolla, California., Cannon TD; Department of Psychology and Psychiatry, Yale University, New Haven, Connecticut., Cornblatt B; Northwell Health, New Hyde Park, New York; Institute for Behavioral Science, Feinstein Institutes for Medical Research, Northwell Health System, Manhasset, New York; Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York., Keshavan M; Department of Psychiatry, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts., Mathalon DH; Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, California; Veterans Affairs San Francisco Health Care System, San Francisco, California., Perkins DO; Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Seidman L; Department of Psychiatry, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts., Stone WS; Department of Psychiatry, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts., Tsuang MT; Department of Psychiatry, University of California San Diego, La Jolla, California., Walker EF; Department of Psychology, Emory University, Atlanta, Georgia., Woods S; Department of Psychiatry, Yale University, New Haven, Connecticut., Brady RO Jr; Department of Psychiatry, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts., Carrión RE; Northwell Health, New Hyde Park, New York; Institute for Behavioral Science, Feinstein Institutes for Medical Research, Northwell Health System, Manhasset, New York; Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York., Ward HB; Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: heather.b.ward@vumc.org.
Source: Biological psychiatry. Cognitive neuroscience and neuroimaging [Biol Psychiatry Cogn Neurosci Neuroimaging] 2026 Apr 16. Date of Electronic Publication: 2026 Apr 16.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 101671285 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2451-9030 (Electronic) Linking ISSN: 24519022 NLM ISO Abbreviation: Biol Psychiatry Cogn Neurosci Neuroimaging Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2451-9030
DOI:10.1016/j.bpsc.2026.03.021